1. Home
  2. PHAR vs EVER Comparison

PHAR vs EVER Comparison

Compare PHAR & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • EVER
  • Stock Information
  • Founded
  • PHAR 1988
  • EVER 2008
  • Country
  • PHAR Netherlands
  • EVER United States
  • Employees
  • PHAR N/A
  • EVER N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • EVER Computer Software: Programming Data Processing
  • Sector
  • PHAR Health Care
  • EVER Technology
  • Exchange
  • PHAR Nasdaq
  • EVER Nasdaq
  • Market Cap
  • PHAR 627.5M
  • EVER 664.3M
  • IPO Year
  • PHAR N/A
  • EVER 2018
  • Fundamental
  • Price
  • PHAR $9.98
  • EVER $18.47
  • Analyst Decision
  • PHAR Strong Buy
  • EVER Strong Buy
  • Analyst Count
  • PHAR 3
  • EVER 6
  • Target Price
  • PHAR $27.00
  • EVER $31.67
  • AVG Volume (30 Days)
  • PHAR 6.0K
  • EVER 442.0K
  • Earning Date
  • PHAR 03-13-2025
  • EVER 02-24-2025
  • Dividend Yield
  • PHAR N/A
  • EVER N/A
  • EPS Growth
  • PHAR N/A
  • EVER N/A
  • EPS
  • PHAR N/A
  • EVER 0.38
  • Revenue
  • PHAR $285,745,000.00
  • EVER $408,440,000.00
  • Revenue This Year
  • PHAR $20.08
  • EVER $72.34
  • Revenue Next Year
  • PHAR $9.22
  • EVER $18.98
  • P/E Ratio
  • PHAR N/A
  • EVER $49.06
  • Revenue Growth
  • PHAR 30.64
  • EVER 27.43
  • 52 Week Low
  • PHAR $6.65
  • EVER $10.65
  • 52 Week High
  • PHAR $13.20
  • EVER $28.09
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 56.13
  • EVER 47.50
  • Support Level
  • PHAR $9.37
  • EVER $17.20
  • Resistance Level
  • PHAR $10.15
  • EVER $19.09
  • Average True Range (ATR)
  • PHAR 0.50
  • EVER 0.84
  • MACD
  • PHAR -0.09
  • EVER -0.08
  • Stochastic Oscillator
  • PHAR 57.53
  • EVER 33.38

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

Share on Social Networks: